Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 238-245

  Lenders, Jacques W M ^a,g   Pacak, Karel ^b   Huynh, Thanh Truc ^b   Sharabi, Yehonatan ^f   Mannelli, Massimo ^e   Bratslavsky, Gennady ^c   Goldstein, David S ^d   Bornstein, Stefan R ^g   Eisenhofer, Graeme ^g  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^e UNIVERSITY OF FLORENCE   (Italy)

^f SHEBA MEDICAL CENTER   (Israel)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; GLUCAGON; GLUCAGON RECEPTOR; METADRENALIN; NORADRENALIN; NORMETADRENALIN;

ADRENAL MEDULLA TUMOR; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; NEUROFIBROMATOSIS; NORADRENALIN BLOOD LEVEL; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SENSITIVITY AND SPECIFICITY; VON HIPPEL LINDAU DISEASE;

EID: 75149141715     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1850     Document Type: Article

References (25)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K 2005 Pheochromocytoma. Lancet 366:665-675
2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G 2002 Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287: 1427-1434
3. Hickman PE, Leong M, Chang J, Wilson SR, McWhinney B 2009 Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of pheochromocytoma. Pathology 41:173-177
4. Václavík J, Stejskal D, Lacnák B, Lazárová M, Jedelský L, Kadalová L, Janosová M, Frysák Z, Vlcek P 2007 Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J Hypertens 25:1427-1431
5. Sawka AM, Jaeschke R, Singh RJ, Young Jr WF 2003 A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88:553-558
6. Lawrence AM 1967 Glucagon provocative test for pheochromocytoma. Ann Int Med 66:1091-1096
7. Sheps SG, Maher FT 1968 Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA 205:895-859
8. Bravo EL, Tarazi RC, Gifford RW, Stewart BH 1979 Circulating and urinary catecholamines in pheochromocytoma: diagnostic and pathophysiologic implications. N Engl J Med 301:682-686
9. Bernini GP, Vivaldi MS, Argenio GF, Moretti A, Sgrò M, Salvetti A 1997 Frequency of pheochromocytoma in adrenal incidentalomas and utility of the glucagon test for the diagnosis. J Endocrinol Invest 20:65-71
10. Levinson PD, Hamilton BP, Mersey JH, Kowarski AA 1983 Plasma normetanephrine and epinephrine responses to glucagon in patients with suspected pheochromocytomas. Metabolism 32:998-1001
11. Grossman E, Goldstein DS, Hoffman A, Keiser HR 1991 Glucagon and clonidine testing in the diagnosis of pheochromocytoma. Hypertension 17:733-741
12. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ 1986 Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030-2033
13. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ 1993 Determination of plasma metanephrines by liquid chromatography with electrochemical detection. Clin Chem 39:97-103
14. Bravo EL, Tagle R 2003 Pheochromocytoma: state of the art and future prospects. Endocr Rev 24:539-553
15. Sebel EF, Hull RD, Kleerekoper M, Stokes GS 1974 Responses to glucagon in hypertensive patients with and without pheochromocytoma. Am J Med Sci 267:337-343
16. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS 2007 Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 3:92-102
17. Bernheim C, Jaillon P, Graisely B, Cloarec M, Debray J, Cheymol G 1978 Merits of the assay of plasma catecholamines in a glucagon test to diagnosis of pheochromocytoma (author's translation). Nouv Presse Med 7:553-555
18. Kuchel O, Hamet P, Buu NT, Larochelle P 1981 Basis of falsepositive glucagon tests for pheochromocytoma. Clin Pharmacol Ther 29:687-694
19. McLoughlin MJ, Langer B, Wilson DR 1981 Life-threatening reaction to glucagon in a patient with pheochromocytoma. Radiology 140:841-845
20. Bisschop PH, Corssmit EP, Baas SJ, Serlie MJ, Endert E, Wiersinga WM, Fliers E 2009 Evaluation of endocrine tests. C: glucagon and clonidine test in phaeochromocytoma. Neth J Med 67:91-95
21. Nakai T, Yamada R, Baba M, Komiya E 1980 A reevaluation of the glucagon provocative test for pheochromocytoma-on the in vitro release of catecholamine from the adrenal medulla or pheochromocytoma tissue, and on the effect of intravenous glucagon on urinary catecholamine excretion and blood pressure. Nippon Naibunpi Gakkai Zasshi 56:855-867
22. Levey GS, Weiss SR, Ruiz E 1975 Characterization of the glucagon receptor in a pheochromocytoma. J Clin Endocrinol Metab 40:720-723
23. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, Pacak K 2003 Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab 88:2656-2666
24. Algeciras-Schimnich A, Preissner CM, Young Jr WF, Singh RJ, Grebe SK 2008 Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 93:91-95
25. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K 2007 Adverse drug reactions in patients with phaeochromocytoma. Drug Safety 30:1031-1062